BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge

BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge

[at noodls] – BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge New company to focus on oral drugs for hepatitis C and hereditary angioedema Combined HCV portfolio includes three complementary viral targeting … more

View todays social media effects on BCRX

View the latest stocks trending across Twitter. Click to view dashboard

Share this post